Alpha-1 antitrypsin deficiency in liver cancer patients
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study looks for a rare cause of liver cancer called alpha-1 antitrypsin deficiency in people whose liver cancer is not due to common causes like alcohol, hepatitis, or fatty liver. If you fit, it could help find an underlying reason for your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of hepatocellular carcinoma (HCC), a type of liver cancer.
- Your liver (outside the tumor) is normal or has only mild to moderate scarring, not advanced cirrhosis.
- You do NOT have other known causes of liver disease, such as heavy alcohol use, fatty liver disease (MASH), hepatitis, or iron overload (hemochromatosis).
- You are willing to sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with a genetic condition called alpha-1 antitrypsin deficiency (a rare protein deficiency) who have liver disease. Researchers will examine stored blood and tissue samples to understand why some people's livers are damaged more than others, which may help develop better treatments.
This trial tests a new blood test to help detect liver cancer (HCC) or confirm it’s not present in people with cirrhosis who are being monitored. It may help improve how doctors screen for liver cancer and decide who needs further imaging or treatment.
This study looks at how alpha-1 antitrypsin deficiency affects the liver in adults. It aims to learn more about the liver problems caused by this condition and may help find better ways to manage them.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
This study looks at your risk of developing liver cancer (hepatocellular carcinoma) if you have a liver condition such as NAFLD or a related disease. It aims to improve how doctors predict who might be at higher risk, so they can offer better monitoring and care.
This study is looking for people with or without liver cancer to test a new way to find liver cancer early using blood or tissue samples. It aims to help catch the disease sooner.
Hear when a new Retrospective Cohort of Patients Diagnosed With HCC on Non-Cirrhotic Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.